U.S. stock markets closed down on Monday, accompanying oil prices, and ahead of a long slate of earnings calls and the Fed’s
decision on interest rates.
Sophiris Bio Inc (NASDAQ: SPHS) rose
35.84 percent during the regular session, and continued to rise more than 5.2 percent in the after-hours session. No particular
news seemed to be driving said spike, which looked like a technical move.
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) traded down more than 3.6 percent after the market closed, even though second
quarter EPS of $3.08 beat the Street’s consensus
by $0.06, and revenue of $7.78 billion was in line with expectations. However, the sales figure implied a 6 percent year-over-year
decline, while net income fell 22 percent and revenue guidance was lowered to $29.5 billion to $30.5 billion, from $30 billion to
$31 billion.
Las Vegas Sands Corp. (NYSE: LVS) returned
more than 2.5 percent after the bell
rang. Even though second quarter EPS of $0.52 and revenue of $2.65 billion missed the Street’s consensus by $0.04 and $110
million, respectively, year-over-year increase in revenue seen over June in the Macau mass-market business suggested some kind of
turnaround could be in the cards.
Texas Instruments Incorporated (NASDAQ: TXN) spiked up more than 5.3
percent, after the company reported EPS of $0.76 per share, $0.03 above the Street’s consensus, on revenue of $3.273 billion,
also slightly ahead of estimates of $3.2 billion.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.